Page last updated: 2024-08-24

zileuton and Bowel Diseases, Inflammatory

zileuton has been researched along with Bowel Diseases, Inflammatory in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bentrem, DJ; Blatner, NR; Cheon, EC; Gounaris, E; Grippo, PJ; Heiferman, JR; Heiferman, MJ; Khazaie, K; Knab, LM; Munshi, HG; Phillips, JD; Shrivastav, M; Vitello, D1
Bruin, KF; Hommes, DW; Jansen, J; Tytgat, GN; van Deventer, SJ; Wouter ten Cate, J1
Ford-Hutchinson, AW1
Camerini, R; Caputi, AP; Graziani, P; Squadrito, F; Zingarelli, B1
Colombel, JF; Desreumaux, P; Ectors, N; Geboes, K; Jouret, A; Rutgeerts, P1

Reviews

2 review(s) available for zileuton and Bowel Diseases, Inflammatory

ArticleYear
Leukotriene antagonists and inhibitors: clinical applications.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23

    Topics: Animals; Asthma; Glomerulonephritis; Humans; Hydroxyurea; Indoles; Inflammatory Bowel Diseases; Leukotriene Antagonists; Leukotrienes; Membrane Proteins; Propionates; Psoriasis; Quinolines; Receptors, Leukotriene

1995
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
    Gastroenterologie clinique et biologique, 1999, Volume: 23, Issue:10

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Cyclosporine; Humans; Hydroxyurea; Ileum; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Microscopy; Sulfasalazine; Time Factors

1999

Other Studies

3 other study(ies) available for zileuton and Bowel Diseases, Inflammatory

ArticleYear
Zileuton, 5-lipoxygenase inhibitor, acts as a chemopreventive agent in intestinal polyposis, by modulating polyp and systemic inflammation.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Animals; Colonic Neoplasms; Disease Models, Animal; Female; Humans; Hydroxyurea; Inflammatory Bowel Diseases; Intestinal Polyposis; Lipoxygenase Inhibitors; Male; Mice; Mice, Mutant Strains

2015
Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.
    European journal of gastroenterology & hepatology, 1995, Volume: 7, Issue:8

    Topics: Aminosalicylic Acids; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dexamethasone; Endotoxins; Humans; Hydroxyurea; In Vitro Techniques; Inflammatory Bowel Diseases; Interleukin-1; Interleukin-6; Leukocytes, Mononuclear; Mesalamine; Sulfapyridine; Tumor Necrosis Factor-alpha

1995
Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats.
    Agents and actions, 1993, Volume: 39, Issue:3-4

    Topics: Animals; Colitis; Colon; Eicosanoids; Hydroxyurea; Inflammatory Bowel Diseases; Leukocytes; Lipoxygenase Inhibitors; Male; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid

1993